Bobak Azamian, MD, PhD (@azamian) header
Bobak Azamian, MD, PhD (@azamian) profile picture

CEO, Tarsus Pharmaceuticals | Biotechnology Entrepreneur | Physician-Scientist

Newport Beach, CA
Joined December 2009
Bobak Azamian, MD, PhD retweeted
At least 185 Iranians have been killed while protesting for freedom. I introduced a bipartisan, bicameral resolution commending those who are demanding freedom & justice. It's co-sponsored by 36 members of the House & 10 Senators, with support growing! tenney.house.gov/media/press…
284
1,168
104
2,636
Bobak Azamian, MD, PhD retweeted
Dear world leaders, we need more than hope and prayers when teenagers are being gunned down in the streets and in their schools. We need action. #OpIran #MahsaAmini #Remembertheirnames @1000daysband
9
59
4
150
Bobak Azamian, MD, PhD retweeted
What’s the magic number of steps to stay healthy?
4
6
4
28
Bobak Azamian, MD, PhD retweeted
In Persian, when behavior comes naturally and effortlessly to someone they say it’s “like they’re drinking water”. The way the Iranian regime’s security forces nonchalantly shoot unarmed civilians (near Sharif University) is like they’re drinking water.
154
1,195
105
2,360
We have something for those ticks!! @TarsusRx
Infectious disease goes on a hike
2
Bobak Azamian, MD, PhD retweeted
Infectious disease goes on a hike
354
2,628
953
17,698
Bobak Azamian, MD, PhD retweeted
"Every moment in darkness is a mortal threat to another young woman." Computational geneticist Dr. Pardis Sabeti dedicates her TIME100 Impact Award to Mahsa Amini and the protesters in Iran ti.me/3rpVzSs
135
837
196
1,792
Bobak Azamian, MD, PhD retweeted
Our team is having a great time at #AAO2022. Thank you @DGlaucomflecken and many others for celebrating with us!
15
5
6
141
Bobak Azamian, MD, PhD retweeted
Today is my birthday. I am 37 years old. I’ll be at the @TarsusRx booth (#1840) today at 2pm. Come celebrate with me. Somebody bring cake. #AAO2022
428
45
18
5,734
Bobak Azamian, MD, PhD retweeted
Getting ready for the Folliculorum Feud!! @TarsusRx @ericdonnenfeld @LizYeu @nedashamie @zaina1225 @LookattheLids
2
2
12
Bobak Azamian, MD, PhD retweeted
I invite feminists and freedom fighters around the world, to join us supporting the Iranian women and people’s uprising against Iranian regime. We don’t need you to save us, but we need West to stop saving this regime. Join us calling them out. #مهسا_امینی #IranRevolution
368
3,132
197
8,401
Bobak Azamian, MD, PhD retweeted
Honored to be a finalist for @Citeline_Awards Clinical Trial Result of the Year for our Phase 2b/3 Saturn-1 pivotal trial evaluating the safety and efficacy of our lead investigational product for the treatment of Demodex blepharitis. https://teapawt.net/t.co/JFSEj1k1bD #CitelineAwards
Bobak Azamian, MD, PhD retweeted
We are proud to be featured in the @NewYorker for our work developing a preventative therapy for Lyme disease. To learn more about the future of Lyme disease prevention, including the science behind our lead candidate, read the article below. #lymedisease #ticks #tickseason
The F.D.A. approved the first Lyme vaccine in 1998. Then, in a rare occurrence in modern medicine, it disappeared. nyer.cm/jGSvfnW
1
3
1
6
Bobak Azamian, MD, PhD retweeted
If you wanna take a break from worrying about Covid, you have mites in your eyelashes and always have
130
97
20
1,282
Thrilled to bring on two new leaders to help us build a great company and scale our passion for delivering new therapies!
Tarsus is building an experienced leadership team to help us achieve our mission of bringing transformational new drugs to patients with unmet needs, starting with Demodex Blepharitis #demodex #blepharitis #optometry #ophthalmology prnewswire.thumbs.top/67Mvo
1
5
Bobak Azamian, MD, PhD retweeted
There are 2.1M diagnoses of blepharitis each year, but no FDA-approved treatments. The Jupiter study evaluated the safety & efficacy of TP-03 for the treatment of Demodex Blepharitis. Read the AOA poster presentation to see how well it did: hubs.ly/H0s0MP90 #ad @tarsusrx
Bobak Azamian, MD, PhD retweeted
Check out our exciting new data from a randomized controlled study of TP-03 to treat Demodex Blepharitis!
There are 2.1M diagnoses of blepharitis each year, but no FDA-approved treatments. The Jupiter study evaluated the safety & efficacy of TP-03 for the treatment of Demodex Blepharitis. Read the AOA poster presentation to see how well it did: hubs.ly/H0s0MP90 #ad @tarsusrx
1
3
Bobak Azamian, MD, PhD retweeted
Check out the positive Phase 2b RCT Jupiter Study results of TP-03 to Treat Demodex Blepharitis that were presented at the AOA 2020 Virtual Meeting! #demodex #blepharitis #optometry #ophthalmology tarsusrx.com/jupiter-study
2
6
Bobak Azamian, MD, PhD retweeted
Check out the highlights of the Mars Phase 2a study of the safety and efficacy of TP-03 for Demodex Blepharitis! #demodex #blepharitis #optometry #ophthalmology #innovation eyetube.net/collections/tars…
3
5